首页 | 本学科首页   官方微博 | 高级检索  
     

心房颤动的药物治疗进展
引用本文:范陈豪[美]. 心房颤动的药物治疗进展[J]. 医学综述, 2012, 18(16): 2596-2599
作者姓名:范陈豪[美]
作者单位:台州市路桥区第二人民医院内科,浙江,台州,318058
摘    要:药物治疗一直是心房颤动处理的基本和主要方法,传统上分为心室率控制、节律控制和抗凝三个方面。合理和规范化联合用药对于控制心房颤动症状以及并发的心力衰竭、脑梗死是十分重要的。此外,为了优化药物或其他高级方案的正确选用,心房颤动新的分类、心电图诊断时的疑难要点、美国脑卒中风险评分CHADS2和欧洲CHA2DS2VASc的异同是研究的重点。

关 键 词:心房颤动  药物治疗  分类  室率和节律控制  抗凝

Progress of Pharmalogical Therapy for Atrial Fibrillation
FAN Chen-hao. Progress of Pharmalogical Therapy for Atrial Fibrillation[J]. Medical Recapitulate, 2012, 18(16): 2596-2599
Authors:FAN Chen-hao
Affiliation:1.Department of Internal Medicine,Luqiao Second People’s Hospital,Taizhou 318058,China;2.Hangzhou Navy Rehabilitation Center,Hangzhou 310002,China)
Abstract:Pharmalogicacol therapy has been the basic and mainstay method in management of atrial fibrillation.This method classically includes 3 aspects of rate control,rhythm control and anti-coagulation.In order to control symptoms as well as complicated heart failure and stroke,rational and standardized use,and combination of medications are paramount.The new classification of the disease,some tricky points in electrocardiographic diagnosis,and comparison between American stroke risk score CHADS2 and European CHA2DS2VASc are important points to be studied so that the choice of drug use or other advanced therapies can be optimized.
Keywords:Atrial fibrillation  Drug therapy  Classification  Rate and rhythm control  Anti-coagulation
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号